Frequency of neural tube defects in Chilean maternity hospitals during 1999;Frecuencia de los defectos de cierre del tubo neural en las maternidades públicas de Santiago durante el año 1999

Revista Medica de Chile

Volumn 129, Issue 3, 2001, Pages 277-284

  Cortés M, Fanny ^a   Mellado S, Cecilia ^a   Hertrampf D, Eva ^a   Alliende R, Angélica ^a   Castillo T, Silvia ^a  

^a HOSPITAL CLÍNICO UNIVERSIDAD DE CHILE   (Chile)

Author keywords

Abnormalities; Folic acid; Neural tube defects; Wheat

Indexed keywords

FOLIC ACID;

ARTICLE; CHILE; DIET SUPPLEMENTATION; FEMALE; FETUS DEATH; FLOUR; HOSPITAL; HUMAN; MALE; NEURAL TUBE DEFECT; NEWBORN; PREGNANCY; PUBLIC HOSPITAL; SEX RATIO; STATISTICS; URBAN POPULATION;

CHILE; FEMALE; FETAL DEATH; FLOUR; FOLIC ACID; FOOD, FORTIFIED; HOSPITALS, MATERNITY; HOSPITALS, PUBLIC; HUMANS; INFANT, NEWBORN; MALE; NEURAL TUBE DEFECTS; PREGNANCY; SEX DISTRIBUTION; URBAN POPULATION;

EID: 0035288257     PISSN: 00349887     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (31)

1. www.minsal.cl
2. NATIONAL BIRTH DEFECT PREVENTION NETWORK. Congenital Malformations Surveillance Report. Teratology 1997; 56 (1/2): 116-75.
3. SMITTHELLS RW, SHEPPARD S, SCHORAH CJ, ET AL. Possible prevention of neural tube defects by periconcepcional vitamin supplementation. Lancet 1980; 1: 339-40.
4. MULINARE J, CORDERO JP, ERICKSON JD, BERRY RJ. Periconceptional use of vitamins and the ocurrence of neural tube defects. JAMA 1988; 260: 3141-5.
5. MILUNSKY A, JICK H, JIK SS, ET AL. Multivitamin/ folic acid supplementation in early pregnancy reduces the prevalence of neural tube defects. JAMA 1989; 262: 2847-52.
6. WERLER P, SHAPIRO S, MITCHELK AA. Periconceptional folic acid exposure and risk of occurrence of neural tube defects. JAMA 1993; 269: 1257-61.
7. MRC VITAMIN STUDY RESEARCH GROUP. Prevention of neural tube defects: results of The Medical Research Council Vitamin Study. Lancet 1991; 338: 131-7.
8. CZEIZEL AE, DUDAS I. Prevention of the first occurrence of neural tube defects by periconceptional vitamin supplementation. N Eng J Med 1992; 327: 1832-5.
9. KIRKE PN, MILLS JL, WHITEHEAD AS, MOLLOY A, SCOTT JM. Methylene tetrahydrofolate reductasa mutation and neural tube defects. Lancet 1996; 348: 1037-8.
10. WHITEHEAD AS, GALLAGHER P, MILLS JL, KIRKE PN, BURKE H, MOLLOY AM, ET AL. A genetic defect in 5,10 methylenetetrahydrofolate reductase in neural tube defects. Q J Med 1995; 88: 763-6.
11. VAN DER PUT NMJ, STEEGERS-THEUNISSEN RPM, FROSST P, TRIJBELS FJM, ESKES TKAB, VAN DER HEUVEL LP, ET AL. Mutated methylenetetrahydrofolate reductase as a risk factor for spina bifida. Lancet 1995; 346: 1070-1.
12. OU CY, STEVENSON RE, BROWN VK, SCHWARTZS CE, ALLEN WP, KHOURY MJ, ET AL. 5,10 methylenetetrahydrofolate reductase genetic polymorphism as a risk factor for neural tube defects. Am J Med Genet 1996; 63: 610-4.
13. CHRISTENSEN B, ARBOUR L, TRAN P, LECLREC D, SABBAGHIAN N, ET AL. Genetic polymorphisms in Methylenetetrahydrofolate reductase and Methionine Synthase, Folate Levels in Red Blood Cells, and Risk of Neural Tube Defects. Am J Med Genet 1999; 84: 151-7.
14. JOHNSON WG, STENROOS ES, HEATH SC, CHEN Y, ET AL. Distribution of Alleles of the Methylenetetrahydrofolate Reductase (MTHFR) C677T Gene Polymorphism in Familial Spina Bifida. Am J Med Genet 1999; 87: 407-12.
15. BAILEY LB, GREGORY JF. Polymorphisms of Methylenetetrahydrofolate Reductase and Other Enzymes: Metabolic Significance, Risks and Impact on Folate Requirement. J Nutr 1999; 129: 919-22.
16. BJORKE-MONSEN AL, UELAND PM, SCHNEEDE J, VOLLSET SE, REFSUM H. Elevated plasma total homocysteine and C677T mutation of the methylenetetrahydrofolate reductase gene in patients with spine bifida. Q J Med 1997; 90: 593-6.
17. STEGMANN K, ZIEGLER A, NGO ET, KOHLSCHMIDT N, SCHROTER B, ERMERT A, KOCH MC. Linkage disequilibrium of MTHFR genotypes 677C/T-1298A/C in the German population and association studies in probands with neural tube defects (NTD). Am J Med Genet 1999; Nov 5; 87: 23-9.
18. HEIL SG, VAN DER PUT NM, TRIJBELS FJ, GABREELS FJ, BLOM HJ. Molecular genetic analysis of human folate receptors in neural tube defects. Eur J Hum Genet 1999; Apr; 7; 393-6.
19. BOTTO LD, YANG Q. 5,10-Methylenetetrahydrofolate Reductasa Gene Variants and Congenital Anomalies: A HuGE Review. Am J Epidemiol 2000; 151: 802-77.
20. SHAW GM, ROZEN R, FINNELL RH, ET AL. Maternal vitamin use, genetic variation of infant methylenetetrahydrofolate reductase, and risk for spina bifida. Am J Epidemiol 1998; 148: 30-7.
21. VAN DER PUT NM, GAUREELS F, STEVENS EM, ET AL. A second common mutation in the methylenetetrahydrofolate reductase gene: an additional risk factor for neural tube defects? Am J Hum Genet 1998; 62: 1044-51.
22. TREMBATH D, SHERBONDY AL, VAMNDYKE DC, ET AL. Analysis of select folate pathway genes, PAX3, and human T in a Midwestern neural tube defect population. Teratology 1999; 59: 331-41.
23. NAZER J, CIFUENTES L, MEZA M. Incidencia de las malformaciones congénitas en 10 maternidades chilenas participantes en el ECLAMC. Comparación de tres períodos (1971-1977, 1982-1988, 1989-1994). Rev Méd Chile 1997; 125: 993-1001.
24. CASTILLA E, LÓPEZ CAMELO J. Análisis de las frecuencias de anencefalia, espina bífida y defecto de tubo neural en Chile. Informe ECLAMC 1999 (19 junio).
25. BERRY RJ, LI ZJ, ERICKSON D, LI S, MOORE CA, WANG H, ET AL. Prevention of Neural Tube Defects with Folic Acid in China. N Eng J Med 1999; 341: 1485-90.
26. WATKINS ML. Efficacy of folic acid prophylaxis for the prevention of neural tube defects. Ment Ret Dev Dis Res Rev 1997; 4: 282-90.
27. CENTERS FOR DISEASE CONTROL AND PREVENTION. Recommendations for the use of folic acid to reduce the number of cases of spina biofida and other neural tube defects. MMWR 1992; 41: 1-7.
28. WALD N, BOWER C. Folic Acid and the Prevention of neural tube defects. BMJ 1995; 310: 1019-20.
29. FOOD AND DRUG ADMINISTRATION: Food Standards: Amendment of standards of identity for enriched grain products of folic acid. Fec Register 1996; 61: 8781-97.
30. CASTILLO C, ATALAH E, BENAVIDES X, URTEAGA C. Patrones alimentarios en población adulta de la Región Metropolitana. Rev Méd Chile 1997; 125: 283-9.
31. CORTÉS F, HIRSCH S, DE LA MAZA MP. Importancia del ácido fólico en la medicina actual. Rev Méd Chile 2000; 128: 213-20.